After Hours
$
71.15
Change
-0.88 -1.22%
Volume
Volume 7,474
Jan 15, 2021, 7:12 p.m.
Quotes are delayed by 20 min
Previous close
$ 71.03
$ 72.03
Change
+1.00 +1.41%
Day low
Day high
$71.39
$72.29

52 week low
52 week high
$49.24
$73.92

Market cap
$165.61B
Average volume
1.13M
P/E ratio
27.15
Rev. per Employee
$422,861
EPS
2.65
Dividend
0.52
Div yield
1.29%
Ex dividend date
8/14/20
MarketWatch News on NVO
-
Novo Nordisk to buy Emisphere for $1.8 billion
- MarketWatch.com
-
Novo Nordisk profit up on destocking, new patients
- MarketWatch.com
-
Banks slump in Europe as stocks lurch toward worst week since June
- Barbara Kollmeyer
-
Novo Nordisk tops estimates as costs fall
- MarketWatch.com
-
A Pioneer ESG Fund Is Still Shooting Out the Lights
- Barron's Online
-
12 European Stocks for the Second Half of 2020
- Barron's Online
-
Stockpiling helps Novo Nordisk beat forecasts
- MarketWatch.com
-
How to Invest in a Time of Turmoil
- Barron's Online
-
Novo Nordisk posts fourth-quarter revenue beat
- MarketWatch.com
-
Sanofi Stock Is Undervalued, J.P. Morgan Says
- Barron's Online
-
Insulin-giant Sanofi to exit diabetes research
- MarketWatch.com
-
Arrowhead Stock’s Surge Will Continue, Analyst Says
- Barron's Online
-
Novo Nordisk downgraded by UBS on concerns over drug launch cost
- Steve Goldstein
-
- Barron's Online
- Loading more headlines...
Analyst Ratings
-
Analysts See a 9.5% Upside for SNY Stock over the Next Year
- MarketRealist.com
-
Analysts’ Updates after Sanofi’s Bioverativ Announcement
- MarketRealist.com
Other News on NVO
-
Nicholas Ward's Dividend Growth Portfolio: 2020 Review
- Seeking Alpha
-
5 Health Care Stocks Outperforming the Benchmark
- GuruFocus.com
-
Novo Nordisk jumps 3% as Alzheimer’s drug enters Phase 3 trial
- Seeking Alpha
- Loading more headlines...
Earnings Announcement
Press Releases on NVO
- Loading more headlines...
Rates »
National averages from Bankrate.com
National averages from Bankrate.com
National averages from Bankrate.com